Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A Web‐Based Survey
Clinical Transplantation · 2024
DOI: 10.1111/ctr.70013 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Mariana Chávez-Villa and 8 co-authors. Institution: Department of Surgery, Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA. Major MEDLINE topics: Liver Transplantation, Living Donors, Liver Neoplasms, Colorectal Neoplasms. 17 references.
Abstract (original language)
Background
Recent advancements in cancer treatment and post‐transplant management have expanded the population of living donor liver transplant (LDLT) candidates. We aimed to examine variations in public acceptance of LDLT based on patient diagnosis, including unresectable colorectal liver metastases (uCRLM).
Methods
A web‐based survey collected demographic information and general perceptions about organ donation in different settings. Respondents indicated their likelihood of being a living liver donor for a family member with genetic liver disease, alcohol‐related liver disease (ALD), and uCRLM. Differences in the likelihood of donation between scenarios were compared.
Results
There were 491 survey respondents (female [76.5%], Caucasians [87.4%], and had at least a college degree [98.2%]). Most (82.4%) were aware of the option of living liver donation before the study and 95% supported living organ donation in general. Over 80% were registered as organ donors. Ninety percent indicated that they would be likely to donate to a family member with a genetic liver disease if they qualified as a living donor; significantly more than ALD (59%) and uCRLM (71%) ( p < 0.001). Willingness to donate to patients with uCRLM was significantly higher ( p < 0.001) than the hypothetical patient with ALD with a clinically accepted recovery period of 6 months.
Conclusions
This study is the first of its kind to assess the public acceptance of living liver donation for uCRLM. Respondents were as or more supportive of donating to uCRLM as they were of generally accepted indications for LT. Further surveys with a broader respondent pool are warranted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgery, Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
- Center for Community Health & Prevention, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Psychiatry, University of Rochester Medical Center, Rochester, New York, USA.
- Liver and Small Bowel Health Centre, King Faisal Special Hospital, Riyadh, Saudi Arabia.
ORCID profiles: Mariana Chávez-Villa, Elizabeth Pope-Collins, Katherine Dokus, John Martens, Elizabeth Keller, Matthew Byrne, Roberto Hernandez-Alejandro, Bandar Al-Judaibi
Cite
APA
Chávez-Villa, M., Pope-Collins, E., Dokus, K., Martens, J., Keller, E., Nickels, M., Byrne, M., Hernandez-Alejandro, R., & Al-Judaibi, B. (2024). Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A Web‐Based Survey. Clinical Transplantation. https://doi.org/10.1111/ctr.70013
Vancouver
Chávez-Villa M, Pope-Collins E, Dokus K, Martens J, Keller E, Nickels M, et al. Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A Web‐Based Survey. Clinical Transplantation. 2024. doi:10.1111/ctr.70013
BibTeX
@article{ChvezVilla2024,
author = {Chávez-Villa, Mariana and Pope-Collins, Elizabeth and Dokus, Katherine and Martens, John and Keller, Elizabeth and Nickels, Mark and Byrne, Matthew and Hernandez-Alejandro, Roberto and Al-Judaibi, Bandar},
title = {Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A Web‐Based Survey},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.70013}
}
EUVIMED